Donnalee Kathleen Papenfuss - 01 Nov 2024 Form 3 Insider Report for FASTENAL CO (FAST)

Signature
/s/ John J. Milek , Attorney-in-Fact
Issuer symbol
FAST
Transactions as of
01 Nov 2024
Net transactions value
$0
Form type
3
Filing time
06 Nov 2024, 17:27:13 UTC
Next filing
12 Nov 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FAST Common Stock 157 01 Nov 2024 Held in 401(K) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FAST Employee Stock Option (Right to Buy) 01 Nov 2024 Common Stock 796 $23.50 Direct F1
holding FAST Employee Stock Option (Right to Buy) 01 Nov 2024 Common Stock 2,364 $27.50 Direct F1
holding FAST Employee Stock Option (Right to Buy) 01 Nov 2024 Common Stock 3,462 $26.00 Direct F2
holding FAST Employee Stock Option (Right to Buy) 01 Nov 2024 Common Stock 3,947 $38.00 Direct F2
holding FAST Employee Stock Option (Right to Buy) 01 Nov 2024 Common Stock 3,125 $48.00 Direct F2
holding FAST Employee Stock Option (Right to Buy) 01 Nov 2024 Common Stock 2,419 $62.00 Direct F2
holding FAST Employee Stock Option (Right to Buy) 01 Nov 2024 Common Stock 3,125 $48.00 Direct F3
holding FAST Employee Stock Option (Right to Buy) 01 Nov 2024 Common Stock 2,343 $64.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will fully vest and become exercisable over a period of eight years, with 25% of the option vesting and becoming exercisable two years after the relevant vesting period, and the remainder vesting and becoming exercisable proportionately (12.5%) each year thereafter.
F2 The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.
F3 The option will fully vest and become exercisable over a period of five years, with 20% vesting and becoming exercisable each year following the grant date.